Drugs / PPP001
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT04461756 | Nov 2018 | — | Tetra Bio-Pharma | Completed | No outcome recorded |
| Phase 1 | NCT04314804 | Mar → Nov 2017 | — | Tetra Bio-Pharma | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03564548 | May 2021 → Mar 2022 | cancer | Tetra Bio-Pharma | Unknown | No outcome recorded |
| Phase 2 | NCT04042545 | Jul 2020 → Sep 2021 | cannabis dependence | Tetra Bio-Pharma | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03339622 | Mar → Dec 2018 | cancer | Tetra Bio-Pharma | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PPP001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03339622 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “inhaled medical cannabis (PPP001)” NCT03339622 ↗ |
| Route | Inhaled | “The inhalation of PPP001 or placebo-kit will be allowed three times a day at 4-6 hour intervals.” NCT03339622 ↗ |